ash111 Wednesday, 11/15/17 02:53:54 AM Re: None Post # of 97121 NURO highly recommended a strong watch. Any positive development might have massively affect due to tiny cap($4m), cash on hand ( $4m cash per 10Q+ recently closed private $3.5M capital raise) and almost Zero debt. Commercial stage. their new Quell product from AMZN 5 stars review.. https://www.amazon.com/Quell-Wearable-Relief-Technology-Starter/dp/B075YVCLZT/ref=dp_ob_image_def#customerReviews 9 transactions since June 2017, ALL Purchases VS zero Sales. https://www.insidermonkey.com/insider-trading/company/neurometrix+inc/1289850/purchases/ Catalysts: 1. There are currently 4 studies underway. http://www.businesswire.com/news/home/20170623005385/en/NeuroMetrix-Update-Quell-Wearable-Pain-Relief-Clinical 2. "third generation Quell platform..expect to launch in 2018" http://investor.neurometrix.com/releasedetail.cfm?ReleaseID=1044503 My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.